| Issue Date | Title | Author(s) |
361 | Dec-2006 | Structure of Halothiobacillus neapolitanus Carboxysomes by Cryo-electron Tomography | Schmid, Michael F.; Paredes, Angel M.; Khant, Htet A.; Soyer Dönmez, Ferda ; Aldrich, Henry C.; Chiu, Wah; Shively, Jessup M. |
362 | Nov-2022 | A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins | Acar, Mustafa Burak; Ayaz Güner, Şerife ; Güner, Hüseyin; Dinç, Gökçen; Ulu Kılıç, Ayşegül; Doğanay, Mehmet; Özcan, Servet |
363 | Oct-2010 | Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells | Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur; Dalmızrak, Ayşegül; Yandım, Melis Kartal; Gündüz, Ufuk; Baran, Yusuf |
364 | Aug-2015 | Sur1-Trpm4 cation channel expression in human cerebral infarcts | Mehta, Rupal I.; Tosun, Çiğdem ; Ivanova, Svetlana; Tsymbalyuk, Natalia; Famakin, Bolanle M.; Kwon, Min Seong; Castellani, Rudy J.; Gerzanich, Volodymyr; Simard, J. Marc |
365 | Dec-2020 | Synergistic antimicrobial effects of activated lactoferrin and rosemary extract in vitro and potential application in meat storage | Soyer, Ferda ; Keman, Deniz ; Eroğlu, Erdal; Türe, Hasan |
366 | 2020 | Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cells | Kaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf |
367 | 20-Apr-2016 | Synthesis and characterization of AICAR and DOX conjugated multifunctional nanoparticles as a platform for synergistic inhibition of cancer cell growth | Dağlıoğlu, Cenk ; Okutucu, Burcu |
368 | 2021 | Synthesis, characterization, and antimicrobial activities of 3-HPAA-Alg-Chi nanoparticles | Özdemir, Özgün Öykü; Soyer, Ferda |
369 | Jan-2017 | Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives | Apohan, Elif; Yılmaz, Ülkü; Yılmaz, Özgür; Serindağ, Ayfer; Küçükbay, Hasan; Yeşilada, Özfer; Baran, Yusuf |
370 | 2021 | Synthesizing and evaluating the photodynamic efficacy of asymmetric heteroleptic A(7)B type novel lanthanide bis-phthalocyanine complexes | Önal, Emel; Tüncel, Özge ; Albakour, Mohamad; Gümüşgöz Çelik, Gizem; Gül Gürek, Ayşe; Özçelik, Serdar |
371 | Jan-2016 | T cells in tumor microenvironment | Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
372 | Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
373 | Oct-2011 | Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation | Baran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim |
374 | Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
375 | Jan-2017 | Therapeutic effects of AICAR and DOX conjugated multifunctional nanoparticles in sensitization and elimination of cancer cells via survivin targeting | Dağlıoğlu, Cenk ; Okutucu, Burcu |
376 | May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
377 | Jan-2013 | Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer | Kartal Yandım, Melis; Apohan, Elif; Baran, Yusuf |
378 | 2020 | Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia | Koca, Duygu; Hastar, Nurcan; Engür, Selin; Kiraz, Yağmur ; Ulu, Gizem Tuğçe ; Çekdemir, Demet; Baran, Yusuf |
379 | Nov-2014 | Thiol peroxidase deficiency leads to increased mutational load and decreased fitness in saccharomyces cerevisiae | Kaya, Alaattin; Lobanov, Alexey V.; Gerashchenko, Maxim V.; Koren, Amnon; Fomenko, Dmitri E.; Koç, Ahmet ; Gladyshev, Vadim N. |
380 | Jun-2006 | Thioredoxin is required for deoxyribonucleotide pool maintenance during S phase | Koç, Ahmet ; Mathews, Christopher K.; Wheeler, Linda J.; Gross, Michael K.; Merrill, Gary Frederic |